Antibody-drug conjugates (ADCs) represent a cutting-edge therapeutic approach that combines the specificity of monoclonal antibodies with the potency of cytotoxic drugs. As these complex molecules gain traction in the pharmaceutical industry, the demand for sophisticated DMPK solutions has skyrocketed. Understanding the intricate pharmacokinetics and metabolism of ADCs is crucial for their successful development and optimization. This article delves into the advanced techniques and comprehensive DMPK services  essential for navigating the complexities of ADC analysis, highlighting the innovative approaches that are shaping the future of this dynamic field.   Table of contents: Innovative Techniques in ADC Stability Studies and Payload Release Monitoring Leveraging LC-HRMS Methods for Unknown Small Molecule Identification in ADCs Comprehensive Drug Discovery DMPK Services for ADC Optimization Advanced Bioanalytical Platforms for ADC DMPK Characterization   Innovati...